| Followers | 122 |
| Posts | 12252 |
| Boards Moderated | 0 |
| Alias Born | 11/08/2021 |
Friday, September 16, 2022 2:48:00 PM
Christopher Brown
FB: https://www.facebook.com/christopher.m.brown.754
Twitter: https://twitter.com/MidwestHedgie
Linkedin: https://www.linkedin.com/in/christopher-brown-5434a751/
Mr. Brown went out of his way to make it look like NWBO's DCVax-L trial had failed during the May 10th presentation of Dr. Paul Mulholland:
They changed to a historical control exactly like I said they would. LOL $NWBOhttps://t.co/b1TLd0VOrt
— Claire, aka Midwestern Hedgie 🇱🇧 (@MidwestHedgie) May 10, 2022
What does Mr. Brown look for when he shorts a stock?
Chris describes how hard it is to short any meme stocks and concentrates his short book on a shareholder base that is largely retail.
What bursts enthusiasm bubbles?
Mr. Brown:
Losing Money
^^ fits exactly with 5-10
Mr. Brown looks to short stocks that
have a very excited investor base, but not particularly knowledgeable
Mr. Brown's strategy can be summed up as:
Why Fight Mike Tyson when you can kick grandma in the shins
What things tend to burn themselves out?
1. Trading at a high enterprise value to revenue
2. burning a lot of cash and dependent on future financing
3. very excited investor base
^^ check check check for NWBO
How much of a short position does Mr. Brown hold in NWBO?
https://contrarianpod.com/content/chris-brown-on-healthcare-tech-stocks-transcribed/
But these days, I mean, you’ve got like, just absolutely, companies with all sorts of ridiculous high jinks that are trading, you know, in the $600 $700 million to $2 billion kind of market cap valuations which you just you know, seeing that kind of stuff is just it’s pretty insane and it’s It makes it, it really makes it challenging on the short side, because things that are just hugely high conviction ideas. I mean, we usually size positions where we’re used to taking some pain and being able to stay in the position.
His short positions seems like it would be sizeable. His fund seems to be ~$200m, half(ish), or more, of which is in short positions. In one of his writings he hinted at 58% of the fund being short. He hinted in the youtube video that he shorts between 60-80 stocks at a time. Nothing out there definitive that he still holds a short position in NWBO, but I'd bet he does and I'd bet it is sizeable.
Why do I dedicate a post to a short hedge fund?!
I think it is important to know that when I state "nefarious forces" are out there trying to destroy NWBO that this is ACTUALLY happening. These forces are all over social media and message boards. They are posting straight out fabrications and half truths on social media every single day. They set false sale dates. They throw out disinformation. They try to build expectations only to crush them even harder when something doesn't pan out. They push false science. They try to build themselves a backstory to blend in with the 'common investor'. At the end of the day, it is important to do your own DD. IMO, long and strong in NWBO will work out in the end. These nefarious forces will not be able to fight the volume that comes with new shareholders once the JA, commercial mfg. approval, RA approvals, an uplisting, etc. all come out. Shorts will burn. Hold tight.
Also, I couldn't have made a better meme picture of the guy than this picture I found on FB so enjoy:
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
